Coronavirus (COVID-19) Update: Daily Roundup September 15, 2020 – FDA.gov

For Immediate Release:
September 15, 2020

The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic:

  • As part of the FDA’s effort to protect consumers, the agency issued warning letters to operators of two websites, www.extrapharma.com and www.medication-house.com, that market unapproved COVID-19 products. There are currently no FDA-approved products to prevent or treat COVID-19. Consumers concerned about COVID-19 should consult with their health care provider. Consumers can visit BeSafeRx to learn how to safely buy medicine online.
  • Testing updates:
    • As of today, 249 tests are authorized by FDA under EUAs; these include 198 molecular tests, 47 antibody tests, and 4 antigen tests.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

###



Related Information

Author: